Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Hypochlorous Acid in Non-Surgical Periodontal Therapy

13 lipca 2026 zaktualizowane przez: Alparslan Dilsiz, Ataturk University

The Effect of Hypochlorous Acid in the Non-Surgical Treatment of Stage I and Stage II Periodontitis

Periodontitis is a chronic inflammatory disease associated with dental plaque and characterized by the progressive destruction of the tooth-supporting tissues. The principal features of periodontitis include clinical attachment loss (CAL), alveolar bone loss, periodontal pocket formation, gingival bleeding, and the subsequent loss of periodontal tissue support.

The current gold standard for the management of periodontal disease comprises oral hygiene instruction (OHI), non-surgical periodontal therapy (NSPT), periodontal surgery when indicated, and supportive periodontal therapy (SPT). In addition, various antimicrobial agents are used as adjuncts to periodontal treatment. One such agent, hypochlorous acid (HOCl), is a potent antimicrobial with high affinity against Gram-negative bacteria within the subgingival biofilm. Hypochlorous acid is commercially available in mouthwash and spray formulations, which patients may use as adjunctive therapies following periodontal treatment.

In the present project, hypochlorous acid will be applied by the clinician using a dental device during periodontal treatment in a clinical setting. Changes in both clinical and biochemical outcomes, including high-sensitivity C-reactive protein (hs-CRP), C-reactive protein (CRP), antistreptolysin O (ASO), and oncostatin M (OSM), will be recorded and compared with those obtained following conventional periodontal treatment performed using purified water.

The novelty of the proposed study lies in the first-time use of hypochlorous acid as an irrigant in place of purified water during scaling and root planing (SRP), with the aim of evaluating its effects on both clinical and biochemical parameters. This project is expected to attract the attention of researchers investigating the treatment of periodontitis and may facilitate publication in high-impact international peer-reviewed journals as well as presentation at prestigious scientific congresses. Furthermore, it will contribute to the training of qualified researchers in periodontology and support the completion of a doctoral dissertation. The findings may also provide preliminary data for future studies aimed at developing hypochlorous acid-based adjunctive therapeutic approaches for the management of periodontitis.

Przegląd badań

Szczegółowy opis

Periodontitis is a chronic inflammatory disease that may ultimately lead to tooth loss as a consequence of bacterial-induced destruction of the periodontal tissues. It is characterized by an inflammatory response to dental plaque within the periodontal connective tissue and alveolar bone, and the nature and magnitude of this host response largely determine disease progression. Scaling and root planing (SRP) is considered the gold standard for the treatment of periodontitis. The cornerstone of non-surgical periodontal therapy is the mechanical removal of microbial biofilm and calculus through SRP. However, SRP alone may not be sufficient to eliminate pathogenic bacteria, as these microorganisms can persist within the gingival tissues and in anatomical areas that are difficult to access using conventional periodontal instrumentation, including deep periodontal pockets, furcation involvements, interproximal areas, and root concavities. Therefore, local or systemic antimicrobial agents and antiseptics have been recommended as adjunctive therapies to improve periodontal treatment outcomes.

Owing to its antimicrobial, anti-inflammatory, and wound-healing properties, hypochlorous acid is currently used in various dental applications, including biofilm eradication, mouth rinses, wound care, endodontic irrigation, root surface conditioning, and the treatment of peri-implantitis.

This study has been designed as a single-center, randomized, controlled, prospective clinical trial to be conducted at the Department of Periodontology, Faculty of Dentistry, Atatürk University. A total of 44 systemically healthy individuals aged 18-65 years diagnosed with Stage I or Stage II periodontitis will be enrolled in the study.

Participants will be randomly allocated into two groups using a coin-toss randomization method:

Test group: Scaling and root planing (SRP) performed using hypochlorous acid. Control group: Scaling and root planing (SRP) performed using purified water.

All participants will receive standardized oral hygiene instructions at baseline. SRP will be performed using an ultrasonic device, with hypochlorous acid as the irrigating solution in the test group and purified water in the control group.

Clinical periodontal parameters will be recorded at baseline and at the 1-month and 3-month follow-up visits. These parameters will include:

Plaque Index (PI) Probing Pocket Depth (PPD) Bleeding on Probing (BOP) Clinical Attachment Level (CAL)

At the same time points, blood and saliva samples will be collected for the analysis of C-reactive protein (CRP), high-sensitivity C-reactive protein (hs-CRP), oncostatin M (OSM), and antistreptolysin O (ASO) using enzyme-linked immunosorbent assay (ELISA).

The primary objective of this study is to evaluate the clinical efficacy of hypochlorous acid as an adjunct to scaling and root planing. The secondary objective is to investigate its effects on systemic inflammatory biomarkers.

The findings of this study are expected to contribute to the current understanding of adjunctive therapeutic strategies in periodontal treatment and to support the clinical application of hypochlorous acid as a practical and effective adjunctive approach in the management of periodontitis.

Typ studiów

Interwencyjne

Zapisy (Rzeczywisty)

44

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

    • Erzurum
      • Erzurum, Erzurum, Turcja (Türkiye)
        • Faculty of Dentistry, Atatürk University

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

  • Dorosły
  • Starszy dorosły

Akceptuje zdrowych ochotników

Nie

Opis

Inclusion Criteria:

  1. Individuals aged 18 to 65 years.
  2. Systemically healthy individuals.
  3. Diagnosis of Stage I or Stage II periodontitis according to the 2017 Classification of Periodontal Diseases.
  4. Probing pocket depth (PPD) ≤5 mm and clinical attachment loss (CAL) ≤4 mm.
  5. Presence of a sufficient number of teeth for periodontal evaluation.
  6. Willingness to participate and ability to provide written informed consent.

Exclusion Criteria:

  1. Patients with contraindications to the use of ultrasonic instrumentation.
  2. Pregnant or lactating women.
  3. Patients receiving anti-inflammatory or antibiotic therapy.
  4. Patients with systemic diseases or medical conditions.
  5. Patients receiving continuous medication for any medical condition.
  6. Patients who have undergone periodontal treatment within the previous 6 months.
  7. Patients presenting with acute dental pain (e.g., pulpitis or apical/periodontal abscess).
  8. Individuals who smoke or consume alcohol.
  9. Presence of fewer than 15 teeth.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Pojedynczy

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Scaling and Root Planing (SRP) with Hypochlorous Acid
Participants will undergo scaling and root planing (SRP) using hypochlorous acid.
Scaling and root planing (SRP) will be performed using an ultrasonic device with a hypochlorous acid solution.
Aktywny komparator: Scaling and Root Planing (SRP) with Purified Water
Participants will undergo scaling and root planing (SRP) using an ultrasonic device with purified water.
Scaling and root planing (SRP) will be performed using an ultrasonic device with purified water.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Clinical Attachment Level (CAL)
Ramy czasowe: Baseline, 1 month and 3 months
Assessment of clinical attachment level (CAL), measured in millimeters, as an indicator of periodontal tissue healing.
Baseline, 1 month and 3 months
Probing Pocket Depth (PPD)
Ramy czasowe: Baseline, 1 month and 3 months
Assessment of probing pocket depth (PPD), measured in millimeters, to evaluate clinical periodontal healing.
Baseline, 1 month and 3 months
Plaque Index (PI)
Ramy czasowe: Baseline, 1 month and 3 months
Assessment of dental plaque accumulation.
Baseline, 1 month and 3 months
Bleeding on Probing (BOP)
Ramy czasowe: Baseline, 1 month and 3 months
Assessment of gingival bleeding following periodontal probing.
Baseline, 1 month and 3 months

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
C-Reactive Protein (CRP)
Ramy czasowe: Baseline, 1 month, and 3 months
Assessment of the systemic inflammatory response by measuring serum C-reactive protein (CRP) levels.
Baseline, 1 month, and 3 months
High-Sensitivity C-Reactive Protein (hs-CRP)
Ramy czasowe: Baseline, 1 month and 3 months
Assessment of low-grade systemic inflammation by measuring high-sensitivity C-reactive protein (hs-CRP) levels.
Baseline, 1 month and 3 months
Oncostatin M (OSM)
Ramy czasowe: Baseline, 1 month and 3 months
Assessment of inflammatory cytokine levels associated with periodontal disease.
Baseline, 1 month and 3 months
Antistreptolysin O (ASO)
Ramy czasowe: Baseline, 1 month and 3 months
Assessment of the systemic immune response associated with streptococcal exposure by measuring antistreptolysin O (ASO) levels.
Baseline, 1 month and 3 months

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

9 października 2025

Zakończenie podstawowe (Rzeczywisty)

15 maja 2026

Ukończenie studiów (Rzeczywisty)

12 czerwca 2026

Daty rejestracji na studia

Pierwszy przesłany

14 czerwca 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

13 lipca 2026

Pierwszy wysłany (Rzeczywisty)

17 lipca 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

17 lipca 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

13 lipca 2026

Ostatnia weryfikacja

1 lipca 2026

Więcej informacji

Terminy związane z tym badaniem

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Opis planu IPD

Individual participant data (IPD) will not be shared due to confidentiality and privacy considerations. As this is a single-center study involving a limited number of participants, no formal data-sharing plan has been established.

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj